MedPath

REFRESH OPTIVE FUSION SENSITIVE

REFRESH OPTIVE FUSION SENSITIVE

Discontinued
DIN Number

02450534

Drug Class

Human

Market Date

Apr 26, 2016

Company
HC

Allergan, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02450534
AIG Number0251696003
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS.
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:13.00*
Health Canada Classification

ACTIVE INGREDIENTS (2)

CARBOXYMETHYLCELLULOSE SODIUMActive
Strength: 0.5 % / W/V
Monograph: CARBOXYMETHYLCELLULOSE SODIUM
GLYCERINEActive
Strength: 1 % / W/V
Monograph: GLYCERINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.